These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38124925)

  • 1. Retracted: Efficacy of TACE+Radiofrequency Ablation+Sorafenib in the Treatment of Patients with Recurrent Liver Cancer and Construction of Prediction Model.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9850243. PubMed ID: 38124925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of TACE+Radiofrequency Ablation+Sorafenib in the Treatment of Patients with Recurrent Liver Cancer and Construction of Prediction Model.
    Sun A; Chen S; Lin M; Zhou D; Zhang H; Sun C; Wang P
    Comput Math Methods Med; 2022; 2022():6879035. PubMed ID: 36118840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study.
    Wang XH; Duan WB; Liang W; Li H; Xie XY; Li SQ; Chen MS; Liang P; Mao XH; Zhou QF
    EClinicalMedicine; 2023 Feb; 56():101816. PubMed ID: 36703645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9837201. PubMed ID: 38074396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer.
    Oncology JO
    J Oncol; 2023; 2023():9805275. PubMed ID: 37564258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma.
    Li Y; Zheng YB; Zhao W; Liu B; Hu BS; He X; Huang JW; Lu LG
    Med Oncol; 2013 Dec; 30(4):730. PubMed ID: 24048774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation.
    Wang X; Liang H; Lu Z
    Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044
    [No Abstract]   [Full Text] [Related]  

  • 9. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and prediction of the efficacy and influencing factors of camrelizumab combined with TACE and sorafenib in the treatment of advanced hepatocellular carcinoma.
    Pan S; Zheng J; Shi C
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12479-12487. PubMed ID: 37450029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Zhu K; Huang J; Lai L; Huang W; Cai M; Zhou J; Guo Y; Chen J
    Radiology; 2018 Jul; 288(1):300-307. PubMed ID: 29688153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Radiological Treatment Modalities of Hepatocellular Carcinoma: A Single-Center Experience from Saudi Arabia.
    Dahlan YM; Shirah BH; Alghamdi AS; Al Kenawi AA; Sanai FM
    Gulf J Oncolog; 2022 May; 1(39):56-62. PubMed ID: 35695347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma.
    Wu Y; Qi H; Cao F; Shen L; Chen S; Xie L; Huang T; Song Z; Zhou D; Fan W
    Front Pharmacol; 2020; 11():1130. PubMed ID: 32903854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9896408. PubMed ID: 37662683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study.
    Ding X; Sun W; Chen J; Li W; Shen Y; Guo X; Teng Y; Liu X; Sun S; Wei J; Li W; Chen H; Liu B
    Front Oncol; 2020; 10():578633. PubMed ID: 33194699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Predictive Value of MRI with Serum Lectin-Reactive Alpha-Fetoprotein for Liver Cancer Recurrence after Percutaneous Radiofrequency Ablation.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9758092. PubMed ID: 37387929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
    Chai B; Wang W; Wang F; Zhou G; Zheng C
    Int J Hyperthermia; 2021; 38(1):1685-1694. PubMed ID: 34843653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer.
    Wang W; Li F; Gan P; Li B; Li S
    Front Surg; 2022; 9():981116. PubMed ID: 36117819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.